These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19854132)

  • 1. Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression.
    Palakurthy RK; Wajapeyee N; Santra MK; Gazin C; Lin L; Gobeil S; Green MR
    Mol Cell; 2009 Oct; 36(2):219-30. PubMed ID: 19854132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells.
    Agarwal S; Amin KS; Jagadeesh S; Baishay G; Rao PG; Barua NC; Bhattacharya S; Banerjee PP
    Mol Cancer; 2013 Aug; 12(1):99. PubMed ID: 24001151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
    Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
    BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intronic long noncoding RNA ANRASSF1 recruits PRC2 to the RASSF1A promoter, reducing the expression of RASSF1A and increasing cell proliferation.
    Beckedorff FC; Ayupe AC; Crocci-Souza R; Amaral MS; Nakaya HI; Soltys DT; Menck CF; Reis EM; Verjovski-Almeida S
    PLoS Genet; 2013; 9(8):e1003705. PubMed ID: 23990798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mahanine reverses an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells.
    Jagadeesh S; Sinha S; Pal BC; Bhattacharya S; Banerjee PP
    Biochem Biophys Res Commun; 2007 Oct; 362(1):212-217. PubMed ID: 17698033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer.
    Liu X; Zhang J; Liu L; Jiang Y; Ji J; Yan R; Zhu Z; Yu Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2835-2844. PubMed ID: 29802960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.
    Benbrahim-Tallaa L; Waterland RA; Dill AL; Webber MM; Waalkes MP
    Environ Health Perspect; 2007 Oct; 115(10):1454-9. PubMed ID: 17938735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner.
    Wang J; Bhutani M; Pathak AK; Lang W; Ren H; Jelinek J; He R; Shen L; Issa JP; Mao L
    Cancer Res; 2007 Nov; 67(22):10647-52. PubMed ID: 18006804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer.
    Wang SH; Liu NH; Wang J; Bai H; Mao L
    Chin Med J (Engl); 2008 Sep; 121(17):1712-21. PubMed ID: 19024105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.
    Suzuki M; Sunaga N; Shames DS; Toyooka S; Gazdar AF; Minna JD
    Cancer Res; 2004 May; 64(9):3137-43. PubMed ID: 15126351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma.
    Korah R; Healy JM; Kunstman JW; Fonseca AL; Ameri AH; Prasad ML; Carling T
    Mol Cancer; 2013 Aug; 12():87. PubMed ID: 23915220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.
    Reu FJ; Leaman DW; Maitra RR; Bae SI; Cherkassky L; Fox MW; Rempinski DR; Beaulieu N; MacLeod AR; Borden EC
    Cancer Res; 2006 Mar; 66(5):2785-93. PubMed ID: 16510600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer.
    Teneng I; Tellez CS; Picchi MA; Klinge DM; Yingling CM; Snider AM; Liu Y; Belinsky SA
    Oncogene; 2015 Jan; 34(5):621-30. PubMed ID: 24469050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenin contributes to bladder cancer tumorigenesis by DNMT3b-mediated MMP2 activation.
    Peres R; Furuya H; Pagano I; Shimizu Y; Hokutan K; Rosser CJ
    Oncotarget; 2016 Jul; 7(28):43109-43123. PubMed ID: 27317771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYCN is recruited to the RASSF1A promoter but is not critical for DNA hypermethylation in neuroblastoma.
    Charlet J; Szemes M; Malik KT; Brown KW
    Mol Carcinog; 2014 May; 53(5):413-20. PubMed ID: 23280764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
    Lee CH; Pan KL; Tang YC; Tsai MH; Cheng AJ; Shen MY; Cheng YM; Huang TT; Lin P
    Oncotarget; 2015 Sep; 6(28):25188-201. PubMed ID: 26317789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
    Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
    JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.